Skip to main content

Table 4 Baseline characteristics of DM patients treated by successful CTO-PCI versus CTO-MT

From: Long-term prognosis of chronic total occlusion treated by successful percutaneous coronary intervention in patients with or without diabetes mellitus: a systematic review and meta-analysis

Study

Age (yrs)

PCI/MT

Male (%)

PCI/MT

Smoker(%)

PCI/MT

HTN (%)

PCI/MT

LVEF(%)

PCI/MT

CTO location (%)

LAD/LCX/RCA

MVD (%)

PCI/MT

J-CTO

PCI/MT

SYNTAX PCI/MT

Claessen et al

61.9 ± 9.5/

62.1 ± 9.4

81.1/85.8

35.4/27.5

69.1/74.5

51.8 ± 10.0/

50.9 ± 11.5

PCI:32.4/27.4/40.2

MT:33.1/23.3/42.9

67.4/81.7

NA/NA

NA/NA

Guo et al

64.1 ± 8.9/

65.6 ± 10.2

68.3/70.6

34.9/37.2

73.5/76.9

53.3 ± 9.1/

51.4 ± 11.1

PCI:40.2/24.5/47.4

MT:27.2/36.0/51.2

77.7/86.4

1.41 ± 0.98/

1.78 ± 1.23

21.5 ± 7.5/

24.6 ± 9.1

Tsai et al

70 ± 12/

70 ± 13

86/88

35/35

85/88

47 ± 12/

47 ± 12

PCI:40/26/52

MT:33/33/63

85/96

2.54 ± 1.00/

2.66 ± 1.00

18 ± 6/

20 ± 7

Yan et al

59.06 ± 9.03/

60.65 ± 10.58

79.3/72.7

55.3/48.8

66.7/69.5

62.0(57.0–66.0)/

61.0(55.0–66.0)

PCI:0/0/100/0

MT:0/0/100/0

71.2/74.1

NA/NA

19(12–21)/

20(13–27)

Flores-Umanzor et al

66.8 ± 10.2/

70.2 ± 10.4

83/79

55/52

82/85

46.9 ± 13.1/

43.0 ± 14.1

PCI:35/16/38

MT:18/19/52

82/87

NA/NA

22.7 ± 10.5/

24.3 ± 12.3

Sanguineti et al

65.5 ± 10.4

82.3

21.8

72.8

55.68 ± 9.01

31.2/25.4/42.8/0.6

64.4

1.45 ± 0.84

NA

  1. DM diabetes mellitus, CTO chronic total occlusion, PCI percutaneous coronary intervention, MT medical treatment, HTN hypertension, LVEF left ventricular ejection fraction, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, MVD multivessel disease, J-CTO Japanese-chronic total occlusion, NA not available